INNOVENT BIO(01801),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01801 INNOVENT BIO

Market Closed 04-24 16:08:27

85.800

+2.800

+3.37%

High86.650	Low81.100	Vol12.66M
Open83.000	D1 Closing83.000	Amplitude6.69%
Mkt Cap148.86B	Tradable Cap148.86B	Total Shares1.74B
T/O1.07B	T/O Rate0.73%	Tradable Shares1.74B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01801","market":"HK","secType":"STK","nameCN":"INNOVENT BIO","latestPrice":85.8,"timestamp":1777018107005,"preClose":83,"halted":0,"volume":12657062,"delay":0,"changeRate":0.03373493975903611,"floatShares":1735000000,"shares":1735000000,"eps":0.5387020961089433,"marketStatus":"Market Closed","change":2.8,"latestTime":"04-24 16:08:27","open":83,"high":86.65,"low":81.1,"amount":1069877188,"amplitude":0.066867,"askPrice":85.8,"askSize":15000,"bidPrice":85.75,"bidSize":65000,"shortable":3,"etf":0,"ttmEps":0.5387020961089433,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1540915200000,"exchange":"SEHK","adjPreClose":83,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":1.1415183626048708,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"INB.HK","impliedVol":0.1788,"impliedVolPercentile":0.0122},"requestUrl":"/m/hq/s/01801","defaultTab":"news","newsList":[{"id":"1114508205","title":"INNOVENT BIO Shares Climb Over 4% in Afternoon Session Following Key Data Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=1114508205","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114508205?lang=en_us&edition=fundamental","pubTime":"2026-04-24 13:46","pubTimestamp":1777009581,"startTime":"0","endTime":"0","summary":"INNOVENT BIO (01801) saw its shares rise more than 4% in afternoon trading. At the time of writing, the stock was up 3.73% to HKD 86.1, with a turnover of HKD 625 million. The movement follows an...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0455707207.USD","LU2097828557.USD","LU2488822045.USD","BK1161","LU2242644610.SGD","LU2097828805.USD","LU2097828631.EUR","BK4585","LU2097828474.EUR","BK4588","BK1589","LU0502904849.HKD","LU2097828714.EUR","LU2328871848.SGD","01801","VXUS","BK1583","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105593446","title":"Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects","url":"https://stock-news.laohu8.com/highlight/detail?id=1105593446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105593446?lang=en_us&edition=fundamental","pubTime":"2026-04-23 14:02","pubTimestamp":1776924147,"startTime":"0","endTime":"0","summary":"Innovative drug stocks experienced broad declines in Hong Kong trading. At the time of writing, 3SBIO (01530) fell 12.73% to HK$21.38. REMEGEN (09995) dropped 6.86% to HK$105.9. INNOVENT BIO (01801)...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DIG","GUSH","159992","LU2097828714.EUR","BWET","DBC","BK1583","01530","DRIP","BK1593","OILU","UGA","BK4570","01801","DRLL","06978","LU2097828631.EUR","OIH","LU2328871848.SGD","03692","HK0000165453.HKD","LU2488822045.USD","USE","OILT","BNO","LU0455707207.USD","BK1191","OILK","BK1574","BK1161","LU2097828557.USD","LU2097828805.USD","09995","DBO","IXC","LU0502904849.HKD","DBE","BK4588","DUG","BK4585","ERX","VDE","USL","LU1969619763.USD","USOI","BK1589","LU2097828474.EUR","IEO","PXJ","VXUS","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629061195","title":"Innovent advances IBI363 into phase 3 MarsLight-11 trial in squamous NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2629061195","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629061195?lang=en_us&edition=fundamental","pubTime":"2026-04-22 08:00","pubTimestamp":1776816038,"startTime":"0","endTime":"0","summary":"Innovent flagged new clinical data for IBI363, its PD-1/IL-2α-biased bispecific fusion protein, for presentation at ASCO 2026 in Chicago on May 29 to June 2.Presentations will cover proof-of-concept results in non-small cell lung cancer across immunotherapy-resistant patients and first-line treatment, positioning IBI363 as a potential new option in a high-need setting.Innovent has moved IBI363 into multiregional pivotal development for immunotherapy-resistant NSCLC, marking a step toward late-stage registration strategy.ASCO 2026 program also includes a phase 3 trial design disclosure for MarsLight-11, which will compare IBI363 with docetaxel in previously treated squamous NSCLC.Separate ASCO 2026 abstracts will present additional clinical studies involving TYVYT  across multiple tumor types, supporting lifecycle expansion efforts.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260422:nNDL66fCVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HK0000165453.HKD","LU0455707207.USD","BK1147","LU2097828474.EUR","LU2097828631.EUR","LU2488822045.USD","BK1589","LU1969619763.USD","BK1161","01911","01801","LU2097828805.USD","LU2097828714.EUR","LU2242644610.SGD","BK1583","LU0502904849.HKD","LU2097828557.USD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180322339","title":"Xie Zhiyu's Q1 Portfolio Revealed: Increased Bets on Chemical and Energy Storage Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1180322339","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180322339?lang=en_us&edition=fundamental","pubTime":"2026-04-21 21:53","pubTimestamp":1776779624,"startTime":"0","endTime":"0","summary":"Prominent fund manager Xie Zhiyu has disclosed his first-quarter portfolio holdings. Taking the Xingquan Herun Mixed Fund as an example, Xie executed a clear sector rotation strategy during the...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGXZ86797644.SGD","IE0008368304.USD","LU0188438112.USD","LU1880383366.USD","SGXZ81163826.USD","LU0819123356.HKD","LU0327786744.USD","LU0228659784.USD","LU1961090484.USD","LU0082770016.SGD","LU0117841782.USD","LU0642271901.SGD","LU1880383440.USD","LU1323998911.USD","LU1548497426.USD","HK0000320264.USD","BK0070","LU0345776255.USD","LU2294711713.HKD","LU1580142542.USD","LU0307460666.USD","LU2357125470.USD","SG9999001846.SGD","LU0229945570.USD","LU0052750758.USD","LU2449936058.SGD","LU0251143458.SGD","LU0192582467.USD","LU0502904849.HKD","LU0128522744.USD","LU0572944931.SGD","LU0516423174.USD","LU0605514214.HKD","LU1152091168.USD","LU1960683339.HKD","LU0531971595.HKD","BK1521","LU2238339852.HKD","LU0067412154.USD","LU1808992512.USD","LU2153592121.USD","LU0577902611.USD","LU1655091616.SGD","LU0572940350.SGD","IE00B8L5B284.USD","LU2298322129.HKD","LU1282649810.SGD","LU0700851271.USD","LU0608807433.USD","01801","LU0509642566.USD","LU2580892862.HKD","LU0634319403.HKD","LU0651947912.USD","LU0140636845.USD","LU0505663152.USD","LU1152091754.HKD","LU0648948544.HKD","LU0762541174.USD","IE00BZ199S13.USD","LU2328871848.SGD","BK0073","LU1224709979.USD","LU0043850808.USD","LU2257852520.SGD","LU1366334651.USD","BK1116","LU1188198961.HKD","LU1880398471.USD","LU0577902298.EUR","LU2348773727.SGD","LU0708995153.HKD","LU0516422440.USD","LU2087589342.USD","LU0501845795.SGD","LU0821914370.USD","LU0898667661.SGD","LU2348774022.SGD","SG9999006514.SGD","LU1146622755.USD","BK0231","LU1303224171.USD","LU1997245177.USD","LU0048597586.USD","LU1504937902.USD","LU0130518102.USD","LU0456827905.SGD","BK1097","LU1861219969.SGD","LU1807302812.USD","LU1008478684.HKD","LU0287142896.SGD","300750","LU0082770016.USD","LU2580892789.USD","BK1517","LU0348805143.USD","LU0348783662.USD","LU0210527791.USD","LU2097828631.EUR","IE0032431581.USD","BK0196","LU0543330566.HKD","LU0823397285.USD","LU0348784397.USD","BK1575","LU0651946864.USD","LU1102505762.USD","LU1196710864.SGD","LU0630378692.HKD","LU0359201885.HKD","LU0823040885.USD","BK0167","LU0823426308.USD","LU0106252389.USD","LU0106259558.USD","SG9999001093.SGD","LU0320764243.SGD","LU0244354667.USD","02423","LU0149534421.HKD","600426","LU1810669033.SGD","LU0417516571.SGD","LU1282649067.USD","LU0329678170.USD","IE00BPRC5H50.USD","LU0348825331.USD","LU0384037296.USD","LU2097829019.USD","LU0370786039.SGD","600160","LU0107464264.USD","IE00BMPRXN33.USD","IE00BZ08YS42.EUR","HK0000151867.HKD","LU0211977185.USD","LU2125910500.SGD","IE0034224299.USD","LU2125910849.SGD","LU0029874905.USD","LU0164880469.USD","LU0823414551.USD","LU1251922891.USD","IE00BZ08YT58.USD","LU0762540952.USD","LU2424517915.HKD","LU1051768304.USD","LU0405327494.USD","LU0791590937.USD","BK1142","LU1568876335.HKD","LU1242518931.SGD","LU0329678337.USD","LU0791591158.USD","IE00B12V2V27.USD","BK0044","LU0072913022.USD","LU1044876610.USD","LU0561508036.HKD","LU2242644610.SGD","LU0856984785.SGD","SG9999014674.SGD","LU2399975544.HKD","LU0441854154.USD","SG9999002828.SGD","LU0049853897.USD","LU0543330483.HKD","LU0011963245.USD","BK1584","LU0890818403.SGD","LU2023250504.SGD","LU2039709279.SGD","LU2360108059.USD","SGXZ62798434.SGD","LU1048596156.SGD","LU1688375341.USD","BK0064","LU1224444064.USD","LU0672654166.SGD","LU0784639295.USD","LU1044875133.USD","LU2152927971.USD","LU0261950983.USD","LU2275660780.HKD","LU1956131251.USD","HK0000306685.HKD","LU2357305700.SGD","LU0588545490.SGD","BK0028","BK0229","LU0823041008.USD","LU0048575426.USD","LU0588545904.SGD","LU1064131003.USD","LU1102505929.USD","HK0000181138.USD","LU0315178854.USD","LU0149721374.USD","SG9999000327.SGD","LU2097828805.USD","BK0072","LU0048388663.USD","SG9999003461.SGD","LU0359201612.USD","LU0762542818.HKD","000683","LU0620787316.HKD","LU2495084118.USD","09969","LU1211504680.USD","BK1502","LU0880133367.SGD","BK0224","HK0000306701.USD","LU1720051017.SGD","LU0054237671.USD","LU0589944569.HKD","BK0061","SG9999001226.SGD","LU0315179316.USD","IE00B3M56506.USD","BK0201","LU1770034418.SGD","EVS.SI","LU0831103253.SGD","LU0708995583.HKD","LU0724618433.USD","BK1588","BK1608","LU1439103000.SGD","LU0261950470.USD","LU0061477393.USD","LU0348735423.USD","LU0823038988.USD","IE00B0JY6N72.USD","BK0251","HK0000181112.HKD","LU0541502299.USD","LU0254981946.USD","LU1979443071.USD","03750","LU2294711473.HKD","LU2476274720.SGD","HBBD.SI","LU0164872284.USD","09988","LU2041044095.USD","BK0152","ALBmain","LU0588545730.USD","LU0588546209.SGD","LU0862451753.SGD","LU0143863198.USD","LU0607220059.USD","LU2488822045.USD","LU1794554557.SGD","SG9999004220.SGD","LU2394011477.USD","LU1201861165.SGD","LU0477156797.USD","LU1328615791.USD","BK1610","BABA","LU2506952253.HKD","LU1969619763.USD","LU0196878994.USD","LU0577902371.SGD","IE00B29SXG58.USD","688099","LU0096374516.USD","LU0251144936.SGD","LU1282651048.USD","LU1880398554.USD","LU0431992006.USD","HK0000320223.HKD","SG9999001903.USD","LU2298321311.HKD","LU2097828714.EUR","LU3063872942.SGD","LU2506952410.USD","IE0003895053.USD","LU0541501648.USD","LU0823413587.USD","SG9999002463.SGD","LU1769817179.HKD","LU1997245094.SGD","BK0188","LU0197773673.USD","LU0611395673.USD","LU0449515922.USD","LU1720051108.HKD","LU0396098781.USD","IE00B0169N27.USD","LU0302445910.USD","LU0499858602.USD","LU1316542783.SGD","IE0003795394.USD","LU2153591404.USD","BK0077","BK1249","BK1615","LU1861214812.USD","LU1328277881.USD","LU2148510915.USD","LU0214875030.USD","LU0823414478.USD","LU0048580855.USD","002008","LU0463099449.HKD","LU2106854487.HKD","LU1769817096.USD","688008","LU0531970944.HKD","LU1515016050.SGD","LU0488056044.USD","LU0173614495.USD","SGXZ49509284.SGD","IE00B5MMRT66.SGD","LU2249611893.SGD","LU0819121731.USD","LU0516423091.SGD","LU2097828557.USD","LU2476274308.USD","LU0449509016.USD","LU0540923850.HKD","SG9999001689.USD","LU0594300179.USD","LU0640798160.USD","IE00B543WZ88.USD","LU0648000940.SGD","LU2506952337.HKD","LU0828237940.HKD","LU0320764755.SGD","LU0675040207.SGD","LU0047713382.USD","LU0348783233.USD","LU0886674414.USD","LU0106959298.USD","IE00BYTNYN87.SGD","LU0164865239.USD","LU1868837565.USD","LU0130103400.USD","LU0469268626.HKD","LU1255011170.USD","BK1618","SG9999000459.SGD","LU0235996351.USD","LU0320764599.SGD","LU0577902538.SGD","LU0072462343.USD","LU1939255532.USD","LU1568876251.USD","BK0214","LU0051755006.USD","LU0862451837.USD","LU2097828474.EUR","LU0264606111.USD","LU0210526637.USD","HK0000286598.CNH","LU0197773160.USD","LU1770036033.HKD","LU0823437842.USD","BK1586","LU0314109678.HKD","LU1242518857.USD","SG9999011746.SGD","LU0169518387.USD","LU0127658192.USD","LU1048588211.SGD","LU0608807946.USD","LU0455707207.USD","LU0868486357.SGD","LU1366334578.USD","SGXZ90724238.SGD","HK0000107257.USD","IE00B8HQ1Z84.USD","LU0417516738.SGD","LU0823397103.USD","LU1282649141.HKD","LU1064130708.USD","BK0015","LU0117844026.USD","LU1934453819.USD","LU0594300419.USD","LU0831093199.SGD","LU0650527681.SGD","LU1820825898.SGD","LU0979878070.USD","605117","LU0054450605.USD","LU0417516902.SGD","LU0164939612.USD","LU1978683503.SGD","IE00BZ08YR35.GBP","LU1917777945.USD","LU1868838027.USD","LU0345775950.USD","BK1589","LU1481107354.HKD","LU1721428347.USD","LU2213484517.USD","LU0269904917.USD","LU0029875118.USD","LU0326948709.USD","LU0871576103.HKD","300308","BK0066","LU0228367735.SGD","LU1719994722.HKD","LU0084288322.USD","LU0572939691.SGD","LU1039395188.USD","LU0823039010.USD","LU2778985437.USD","BK1583","LU0823413660.USD","LU0823426480.USD","BK1161","LU0499858438.USD","LU0865486749.SGD","LU1282651121.HKD","LU0143863784.USD","LU0312595415.SGD","LU0128522157.USD","LU2506951792.HKD","LU0181495838.USD","LU0828237510.HKD","IE00BYQNZ168.SGD","LU1813983027.USD","LU1974910355.USD","LU0348788117.USD","LU0132412106.USD","LU2092937221.SGD","LU0405327148.USD","LU1051769294.HKD","LU2289578879.USD","LU0593848301.USD","LU0261947096.USD","688120","LU0630378429.USD","LU2298064838.USD","LU1023057109.AUD","LU1993786604.SGD","LU0259732245.USD","SG9999002562.SGD","LU2293587155.HKD","BK0187","LU1044874839.SGD","89988","LU0737861772.HKD","HK0000165453.HKD","LU0163747925.USD","LU0516422952.EUR","LU0293314216.USD","LU1048484197.HKD","LU0231483743.USD","LU1981816686.USD","LU1720050803.USD","SG9999001051.SGD","LU0737861699.HKD","LU0516422366.SGD","LU0828238088.HKD","LU1781817850.SGD","BK1501","LU0326950275.SGD","LU0348827113.USD","LU0456846285.SGD","LU1115378108.SGD","BK1591","LU0039217434.USD","LU0359202008.SGD","LU0328353924.USD","LU0124384867.USD","IE00BMPRXR70.SGD","LU1642822792.SGD","SG9999006597.SGD","LU2360107325.USD","LU2045819591.USD","LU1831875114.USD","LU0456842615.SGD","IE00BD6J9T35.USD","LU1997244956.HKD","BK1574","LU0165289439.USD","LU2477742899.HKD","IE0003851619.USD","LU0577902454.USD","LU0873338254.USD","LU1655091459.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133238716","title":"CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1133238716","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133238716?lang=en_us&edition=fundamental","pubTime":"2026-04-20 13:50","pubTimestamp":1776664224,"startTime":"0","endTime":"0","summary":"According to a research report from CMB International, the MSCI China Healthcare Index has risen 12.3% since the beginning of 2026, outperforming the MSCI China Index by 13.6%. Recent policy...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","159891","HK0000165453.HKD","BK1191","BK1583","LU2488822045.USD","01167","03692","SG9999014674.SGD","LU0502904849.HKD","LU2097828557.USD","LU2328871848.SGD","LU2097828474.EUR","BK1141","BK1589","LU2097828631.EUR","LU2097828805.USD","LU1969619763.USD","LU2242644610.SGD","02268","BK1574","LU2097828714.EUR","01530","BK1593","LU0455707207.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124678664","title":"China International Capital Corporation: National Policy Optimizes Initial Pricing Mechanism for Innovative Drugs, Pharmaceutical Sector Set for High-Quality Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1124678664","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124678664?lang=en_us&edition=fundamental","pubTime":"2026-04-16 14:39","pubTimestamp":1776321543,"startTime":"0","endTime":"0","summary":"China International Capital Corporation (CICC) has released a research report stating that on April 14th, the General Office of the State Council issued the \"Several Opinions on Improving the Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348825331.USD","LU2097828805.USD","LU2778985437.USD","BK1191","LU2097828474.EUR","LU2543165471.USD","IPOS","LU0348735423.USD","LU1023057109.AUD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1303224171.USD","LU1720050803.USD","HK0000500386.USD","LU1251922891.USD","LU0359202008.SGD","09606","LU0348783233.USD","IE00B543WZ88.USD","LU2097828714.EUR","LU0359201612.USD","LU2476274308.USD","LU0196878994.USD","LU0348766576.USD","BK1583","159992","LU0417516738.SGD","BK1500","LU0455707207.USD","LU1961090484.USD","LU2399975544.HKD","BK1161","IE00BPRC5H50.USD","LU1770034418.SGD","HK0000252160.HKD","06990","LU2488822045.USD","LU2328871848.SGD","HK0000252152.HKD","LU0307460666.USD","06978","BK1588","BK1589","LU0348767384.USD","LU1794554557.SGD","LU0561508036.HKD","06160","LU0634319403.HKD","LU0540923850.HKD","LU0359201885.HKD","LU1719994722.HKD","LU2476274720.SGD","LU0417516571.SGD","LU2097828631.EUR","LU0348827113.USD","LU2097828557.USD","LU0417516902.SGD","01801","LU0588546209.SGD","01276","LU1969619763.USD","LU0348784397.USD","LU0502904849.HKD","LU2242644610.SGD","09926","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114458639","title":"INNOVENT BIO Establishes New Pharmaceutical Firm in Shanghai","url":"https://stock-news.laohu8.com/highlight/detail?id=1114458639","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114458639?lang=en_us&edition=fundamental","pubTime":"2026-04-15 14:50","pubTimestamp":1776235835,"startTime":"0","endTime":"0","summary":"Recent corporate registry records show that Shanghai Zhongxu Jiahe Pharmaceutical Co., Ltd. has been established. The company's legal representative is Guan Zhanqi. Its business scope includes...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU2097828631.EUR","LU2242644610.SGD","LU2097828557.USD","LU2488822045.USD","LU0455707207.USD","LU2097828474.EUR","LU0502904849.HKD","LU2097828805.USD","LU2328871848.SGD","HK0000165453.HKD","LU1969619763.USD","LU2097828714.EUR","BK1589","BK1583","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102623006","title":"Stock Track | Innovent Biologics Soars 5.04% Intraday on GLP-1 Weight-Loss Drug Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1102623006","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102623006?lang=en_us&edition=fundamental","pubTime":"2026-04-15 13:27","pubTimestamp":1776230856,"startTime":"0","endTime":"0","summary":"Innovent Biologics' stock soared 5.04% during intraday trading on Wednesday, following positive regulatory news for its pipeline.The surge came after China's National Medical Products Administration...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627808744","title":"Assessing Innovent Biologics (SEHK:1801) Valuation After New IBI3055 Autoimmune Preclinical Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2627808744","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627808744?lang=en_us&edition=fundamental","pubTime":"2026-04-13 12:39","pubTimestamp":1776055169,"startTime":"0","endTime":"0","summary":"Innovent Biologics (SEHK:1801) shares moved in response to fresh product news after the company presented initial preclinical data for IBI3055, a tri specific anti CD19/BCMA/CD3 T cell engager for autoimmune diseases, in Boston.\nSee our latest analysis for Innovent Biologics.\nThe latest IBI3055 update lands after a mixed but generally positive stretch for investors, with a 30 day share price return of 9.46%, year to date share price return of 12.31%, and a 1 year total shareholder return of...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/assessing-innovent-biologics-sehk1801-valuation-after-new-ib","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/assessing-innovent-biologics-sehk1801-valuation-after-new-ib","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2097828557.USD","BK1161","LU2097828714.EUR","HK0000165453.HKD","LU2097828474.EUR","DCF","LU0455707207.USD","LU2097828631.EUR","BK1583","LU0502904849.HKD","LU2097828805.USD","01801","LU2328871848.SGD","LU2488822045.USD","BK1589","LU1969619763.USD","LU2242644610.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626159507","title":"Innovent presents preclinical data on IBI3055 at Immune Resetting Summit 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2626159507","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626159507?lang=en_us&edition=fundamental","pubTime":"2026-04-10 08:00","pubTimestamp":1775779217,"startTime":"0","endTime":"0","summary":"Innovent presented at 2026 Immune Resetting: B-Cell Mediated & Beyond Summit in Boston on April 9, 2026.Oral presentation disclosed preclinical data for IBI3055, a CD19/BCMA/CD3 tri-specific T-cell engager that depleted B cells and plasma cells in animal studies while showing favorable tolerability in non-human primates.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL1Gg9NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","01911","HK0000165453.HKD","BK1161","01801","LU2097828557.USD","BK1147","LU2097828474.EUR","BK1589","LU2328871848.SGD","LU0502904849.HKD","BK1583","LU2097828805.USD","LU1969619763.USD","LU2097828631.EUR","LU0455707207.USD","LU2097828714.EUR","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626595571","title":"Immune Resetting: B-Cell Mediated & Beyond Summit 2026 Oral Presentation: Innovent Biologics Announces Pre-Clinical Results of Ibi3055, a Tri-Specific T Cell Engager Targeting Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2626595571","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626595571?lang=en_us&edition=fundamental","pubTime":"2026-04-10 08:00","pubTimestamp":1775779200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nTUA1KV9WZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","LU2097828631.EUR","LU2242644610.SGD","LU2097828557.USD","LU2488822045.USD","LU0455707207.USD","LU2097828474.EUR","LU0502904849.HKD","LU2097828805.USD","LU2328871848.SGD","HK0000165453.HKD","LU1969619763.USD","LU2097828714.EUR","BK1589","BK1583","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125704924","title":"Interview with Xellar Technology's Xie Xin: Organ-on-a-Chip Commercialization Gains Momentum as Pharma Pays to Reduce R&D Uncertainty and Failure Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=1125704924","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125704924?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:24","pubTimestamp":1775651061,"startTime":"0","endTime":"0","summary":"Animal testing has long served as the safety foundation for new drug development. However, regulatory shifts are quietly changing this paradigm. On April 10, 2025, the FDA released its \"Roadmap for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4535","BK4585","BK4588","01801"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146850918","title":"INNOVENT BIO Shares Reduced by Ede Ronald Hao Xi in HK$85 Million Transaction","url":"https://stock-news.laohu8.com/highlight/detail?id=1146850918","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146850918?lang=en_us&edition=fundamental","pubTime":"2026-04-07 09:40","pubTimestamp":1775526024,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on March 30, Ede Ronald Hao Xi reduced his holdings in INNOVENT BIO (01801) by 1 million shares. The shares were sold at a price of HK$85.0005...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2097828631.EUR","LU2488822045.USD","EWH","BK1589","01801","LU2097828557.USD","LU2328871848.SGD","LU0455707207.USD","LU1969619763.USD","HK0000165453.HKD","LU2097828474.EUR","LU2097828714.EUR","LU2242644610.SGD","BK1583","LU2097828805.USD","BK1161","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110976237","title":"Ede Ronald Hao Xi Sells 1 Million Shares of Innovent Bio at HK$85 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=1110976237","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110976237?lang=en_us&edition=fundamental","pubTime":"2026-04-04 19:26","pubTimestamp":1775301974,"startTime":"0","endTime":"0","summary":"On March 30, Ede Ronald Hao Xi reduced his stake in Innovent Bio (01801) by selling 1 million shares at a price of HK$85.0005 per share. The total value of the transaction amounted to HK$85.0005...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","EWH","LU2097828474.EUR","LU2097828631.EUR","LU2328871848.SGD","LU2488822045.USD","LU0502904849.HKD","LU2097828557.USD","01801","LU2097828714.EUR","LU2242644610.SGD","LU2097828805.USD","BK1589","HK0000165453.HKD","BK1161","LU1969619763.USD","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154925603","title":"Business Travelers Can Now Earn Rewards Points for Hotel Stays, Industry Explores Innovative Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=1154925603","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154925603?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:22","pubTimestamp":1775038971,"startTime":"0","endTime":"0","summary":"Jinjiang Hotels has comprehensively upgraded its corporate membership points benefits, increasing direct sales efforts to build a broader membership ecosystem. Business travelers staying in hotels...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2552382215.SGD","LU0057025933.USD","LU1815333072.USD","LU2458330169.SGD","LU0256863902.USD","LU2505996509.AUD","IE00BK4W5L77.USD","LU2456880835.USD","LU0215105999.USD","LU0738911758.USD","LU0354030511.USD","IE00BLSP4452.SGD","LU0784385840.USD","LU1035775433.USD","LU2242649171.HKD","LU1642822529.SGD","LU0069063385.USD","LU1629891620.HKD","LU2471134796.USD","LU0096362180.USD","LU0820561909.HKD","BK4598","LU2250418816.HKD","BK4527","LU2417539215.USD","LU0127658192.USD","LU2487616109.SGD","SG9999002224.SGD","SG9999018865.SGD","IE00BN29S564.USD","LU0942090050.USD","LU2357305700.SGD","AAPW","LU2462157665.USD","IE0009356076.USD","IE00B19Z8W00.USD","IE00BJJMRX11.SGD","LU1116320737.USD","LU0823421333.USD","LU0965508806.USD","LU1244550494.USD","LU0082616367.USD","LU0345770993.USD","AAPD","LU1674673428.USD","IE0005OL40V9.USD","BK4585","IE0034235295.USD","LU2191332357.HKD","SG9999015986.USD","LU1244550221.USD","LU1046421795.USD","LU1868836757.USD","LU1066051811.HKD","LU1718418525.SGD","LU0345769631.USD","LU1037948897.HKD","AAPB","LU0170899867.USD","SG9999014906.USD","LU1791710582.SGD","SG9999002232.USD","BK4507","LU2065169927.USD","LU1301847155.USD","IE00BDCRKT87.USD","BK4576","LU2552382132.HKD","LU0234570918.USD","LU2065171311.SGD","IE00B19Z8X17.USD","BK4571","LU2106854487.HKD","LU2430703251.USD","IE00BKVL7J92.USD","LU2023250843.SGD","LU0251132253.USD","LU0528227936.USD","LU2023251221.USD","LU2097344431.USD","LU2168564065.EUR","LU1242518857.USD","LU0210536198.USD","LU0943347566.SGD","BK4550","LU0203202063.USD","LU0965509283.SGD","LU2125154778.USD","LU0158827948.USD","IE00BYXW3230.USD","IE00BN8TJ469.HKD","LU0784383803.USD","LU2023250330.USD","BK4505","LU0820562030.AUD","LU0784384876.USD","LU1366192091.USD","LU0726765562.USD","LU0965509101.SGD","LU1582987324.SGD","LU0957808578.USD","HK0000914686.HKD","LU2271345857.HKD","IE00BFSS7M15.SGD","BK4512","LU1804176565.USD","LU2111349929.HKD","LU1989772840.SGD","BK4534","LU0077335932.USD","IE000ITXATA3.USD","LU0265550946.USD","LU0795875086.SGD","LU0157215616.USD","LU2168564222.USD","AAPX","LU1914381329.SGD","LU2089283258.USD","LU1242518931.SGD","LU0267386448.USD","LU2054465674.USD","LU0070217475.USD","BK4574","LU0061474960.USD","BK4170","LU1551013425.SGD","IE00B1BXHZ80.USD","LU2756315318.SGD","LU0964807845.USD","LU0689626769.HKD","HK0000320264.USD","LU0314106906.USD","LU0096364046.USD","LU2023250504.SGD","LU0642271901.SGD","IE00BLSP4239.USD","LU0417517546.SGD","LU0949170772.SGD","LU2471134523.USD","LU1778281490.HKD","LU1069344957.HKD","SG9999001424.SGD","IE0003U64NQ7.SGD","LU1366333091.USD","LU0661504455.SGD","LU1496350171.SGD","SG9999000418.SGD","LU2361045086.USD","LU0724617625.USD","IE0004091025.USD","LU2361044949.HKD","LU1989764748.USD","LU2265009873.SGD","LU1261432733.SGD","IE0009G5SDU7.USD","LU0882574139.USD","LU0957791311.USD","LU2452424414.USD","LU0985320562.USD","IE00BJJMRY28.SGD","LU0689472784.USD","LU0109391861.USD","LU1989771016.USD","LU2746668974.SGD","IE00B4JS1V06.HKD","LU2403377893.USD","LU0545039389.USD","MACW.SI","LU0444971666.USD","LU1291159041.SGD","LU2168563687.JPY","LU2458330243.SGD","LU0316494557.USD","LU2236285917.USD","LU1506573853.SGD","LU2750360641.GBP","LU0314104364.USD","IE00BK4W5M84.HKD","SG9999014575.USD","LU1235294995.USD","LU0823434583.USD","LU0320765059.SGD","BK4575","SGXZ31699556.SGD","LU2860962120.EUR","LU2092937148.SGD","LU2063271972.USD","LU1839511570.USD","01801","LU1582986359.USD","LU0198837287.USD","LU2461242641.AUD","SG9999014880.SGD","IE00BDRTCR15.USD","LU0210528500.USD","LU0494093205.USD","LU0265550359.USD","LU1066051498.USD","LU2028103732.USD","IE00B1XK9C88.USD","LU2097344357.USD","LU1280957306.USD","LU2092627202.USD","LU1571399168.USD","LU1935042488.USD","LU1791710400.SGD","IE00B5949003.HKD","LU0787776722.HKD","AAPL","IE00B775H168.HKD","LU1116320901.HKD","BK4501","LU0238689110.USD","LU1935042991.SGD","LU0786609619.USD","BK4553","LU2242650005.HKD","LU1582987597.SGD","BK4532","LU2237443895.HKD","LU0820561818.USD","LU0472753341.HKD","LU1551013342.USD","LU1868837136.USD","LU2602419157.SGD","LU2381873111.SGD","LU0949170426.SGD","LU1989772923.USD","LU1732800096.USD","IE0004445015.USD","LU1582986433.USD","LU1145028129.USD","LU0823421416.USD","LU0056508442.USD","LU2361044865.SGD","LU0640476718.USD","LU0788109477.HKD","LU0345768153.USD","IE00BJLML261.HKD","LU1934455277.USD","LU2125154935.USD","IE0034235303.USD","LU0354030438.USD","AAPY","BK4559","LU1232071149.USD","LU0476273544.USD","LU0289739343.SGD","LU0456855351.SGD","APLY","LU2237443382.USD","SG9999014542.SGD","LU1720051017.SGD","LU0061475181.USD","IE00BFSS8Q28.SGD","LU2471134952.CNY","LU1934455194.USD","SG9999014567.USD","LU0348723411.USD","SG9999018857.SGD","LU1917777945.USD","SG9999014898.SGD","LU0823434740.USD","LU1206713676.USD","SG9999015341.SGD","IE00B4YYXB79.USD","LU0511384066.AUD","LU0079474960.USD","SG9999017495.SGD","LU1868837300.USD","LU2237443549.SGD","LU1934455863.HKD","BK4579","LU0868494708.USD","LU0308772762.SGD","IE00BJTD4V19.USD","IE000YTNTUN2.SGD","SG9999015978.USD","LU2168564495.EUR","LU2247934214.USD","LU1803068979.SGD","IE00B3S45H60.SGD","LU2360032135.SGD","LU1066053197.SGD","BK4515","LU1935042215.USD","BK4592","LU0672654240.SGD","LU1316542783.SGD","LU0553294199.USD","SG9999015358.SGD","LU2347655156.SGD","LU2083900584.USD","LU0965509010.AUD","LU2237438978.USD","LU2237443978.SGD","LU2746668461.USD","BK4533","LU1868836591.USD","LU2471134879.HKD","LU0345768740.USD","BK4573","LU0353189680.USD","LU2420271590.USD","IE00B3SWFQ91.USD","LU2077746001.SGD","LU2543165471.USD","LU0011850046.USD","LU1066051225.USD","LU0719512351.SGD","BK4581","LU1699723380.USD","LU1674673691.USD","LU0784385170.HKD","LU1496350502.SGD","LU2065170008.USD","LU2360106780.USD","LU0345770308.USD","LU1720051108.HKD","IE00B7KXQ091.USD","IE00BBT3K403.USD","LU1119994496.HKD","LU0683600562.USD","LU1823568750.SGD","LU0353189763.USD","LU0444973449.USD","LU0256863811.USD","LU0072462426.USD","LU1732799900.SGD","IE000KEQY171.SGD","LU0210533765.USD","BK4566","LU0080751232.USD","IE0004445239.USD","LU0154236417.USD","IE00BWXC8680.SGD","LU0861579265.USD","GB00BDT5M118.USD","LU0124676726.USD","SG9999015952.SGD","LU1037948541.HKD","LU0109392836.USD","LU2430703178.SGD","LU0868494617.USD","LU2750360997.AUD","LU1868836914.USD","LU2237443622.USD","LU2552382058.USD","IE0001KFT4U8.USD","LU2286300806.USD","BK4588","LU2089284900.SGD","IE000W1ABFV2.USD","LU0466842654.USD","LU1815336760.USD","LU0053666078.USD","LU1989764664.SGD","HK0000320223.HKD","LU2087621335.USD","LU2237443465.HKD","LU0158827781.USD","LU0234572021.USD","LU0048584097.USD","LU0708995401.HKD","BK4554","LU0081259029.USD","LU0097036916.USD","LU0323591593.USD","LU0149725797.USD","LU0979878070.USD","LU2430703095.HKD","LU0889565833.HKD","LU1548497426.USD","LU0912757837.SGD","LU2133065610.SGD","HK0000914660.USD","IE00BJTD4N35.SGD","01585","SG9999015945.SGD","IE00B19Z9505.USD","LU1244550577.SGD","HK0000306685.HKD","LU2592432038.USD","SG9999014559.SGD","LU0795875169.SGD","LU1814569148.SGD","LU2505996681.GBP","LU0203201768.USD","LU2896262040.SGD","LU1084165304.USD","LU1935043023.USD","LU1935043536.SGD","IE00BKDWB100.SGD","IE0004086264.USD","LU2087625088.SGD","IE00BSNM7G36.USD","LU2168564149.EUR","LU1267930730.SGD","IE00BZ1G4Q59.USD","LU0345769128.USD","LU1974910355.USD","LU2108987350.USD","LU2065171402.SGD","HK0000306701.USD","LU2756315664.SGD","LU1206712785.SGD","LU1003077747.HKD","LU1852331112.SGD","IE00B775SV38.USD","LU1127390331.HKD","SG9999014914.USD","LU0289961442.SGD","LU2213496289.HKD","AAPU","LU2347655073.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149947754","title":"INNOVENT BIO Grants 1.94 Million Share Options and 10.24 Million Restricted Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1149947754","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149947754?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:22","pubTimestamp":1774916532,"startTime":"0","endTime":"0","summary":"INNOVENT BIO (01801) announced that on March 30, 2026, the company granted 1.94 million share options to 66 grantees, including directors, and issued 10.24 million restricted shares to 1,308 grantees under the terms of the 2024 Share Scheme, subject to acceptance by the recipients.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242644610.SGD","LU2097828557.USD","BK1589","BK1583","LU1969619763.USD","LU0502904849.HKD","HK0000165453.HKD","01801","LU2097828805.USD","LU2488822045.USD","BK1161","LU2328871848.SGD","LU2097828631.EUR","LU2097828474.EUR","LU2097828714.EUR","LU0455707207.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623320255","title":"Innovent partner Ollin says OLN324 beats Roche’s Vabysmo on DME anatomy in Phase 1b trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2623320255","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623320255?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:00","pubTimestamp":1774915229,"startTime":"0","endTime":"0","summary":"Innovent partner Ollin Biosciences released final 20-week data from Phase 1b JADE head-to-head study of OLN324  versus Roche’s Vabysmo in diabetic macular edema or wet age-related macular degeneration.Results showed OLN324 delivered stronger anatomic improvements in diabetic macular edema, with vision gains that held up through follow-up.Wet age-related macular degeneration data showed comparable fluid control, with a widening edge in vision outcomes for OLN324 by study end.Newly available anatomic analyses indicated faster, greater, more durable reductions in pigment epithelial detachments versus Vabysmo.Full data set is expected to be presented at upcoming medical meetings, with global Phase 3 studies planned for 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL9qWvky:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","LU2097828714.EUR","LU2097828805.USD","LU2242644610.SGD","LU2328871848.SGD","LU0455707207.USD","LU0502904849.HKD","01801","LU2097828474.EUR","LU2488822045.USD","BK1583","LU1969619763.USD","LU2097828557.USD","01911","HK0000165453.HKD","BK1161","LU2097828631.EUR","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623172320","title":"Innovent's Partner Ollin Biosciences Announces Final Data From Randomized Head-to-Head Study of Ibi324 Compared to Faricimab (Vabysmo) in Wet Age-Related Macular Degeneration and Diabetic Macular Edema","url":"https://stock-news.laohu8.com/highlight/detail?id=2623172320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623172320?lang=en_us&edition=fundamental","pubTime":"2026-03-31 08:00","pubTimestamp":1774915200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nTUA7PDSJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HK0000165453.HKD","BK1589","01801","LU0455707207.USD","BK1583","LU2097828557.USD","LU0502904849.HKD","LU2488822045.USD","LU2097828714.EUR","BK1161","LU2242644610.SGD","LU2097828805.USD","LU2097828631.EUR","LU2097828474.EUR","LU1969619763.USD","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623327692","title":"Innovent Biologics grants 10.2 million restricted shares under 2024 share scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2623327692","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623327692?lang=en_us&edition=fundamental","pubTime":"2026-03-31 07:02","pubTimestamp":1774911746,"startTime":"0","endTime":"0","summary":"Innovent Biologics granted 1,935,642 share options under 2024 Share Scheme, priced at HK$86.10 per share.Company also granted 10,241,272 restricted shares with nil consideration, implying market value of about HK$880 million at HK$86.10 per share.Directors received 706,549 options; chairman and CEO De-Chao Michael Yu received 486,000.Directors received 1,847,721 restricted shares; Yu received 1,377,000.Options run for 10 years from March 30, 2026; most employee awards vest 75% on March 30, 2029, with remaining 25% on March 30, 2030.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Innovent Biologics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDL4tPwH9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1147","LU2097828714.EUR","LU2097828805.USD","LU2242644610.SGD","LU2328871848.SGD","LU0455707207.USD","LU0502904849.HKD","01801","LU2097828474.EUR","LU2488822045.USD","BK1583","LU1969619763.USD","LU2097828557.USD","01911","HK0000165453.HKD","BK1161","LU2097828631.EUR","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623313067","title":"A Look At Innovent Biologics (SEHK:1801) Valuation After Recent Share Price Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2623313067","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623313067?lang=en_us&edition=fundamental","pubTime":"2026-03-30 16:13","pubTimestamp":1774858391,"startTime":"0","endTime":"0","summary":"Innovent Biologics (SEHK:1801) has drawn investor attention after recent share price moves, with the stock up 7.7% over the past day and 5.5% over the past week, inviting a closer look at its current valuation.\nSee our latest analysis for Innovent Biologics.\nThat 7.7% 1 day share price return and 8.5% year to date share price return sit against a 1 year total shareholder return of 85.1% and a 3 year total shareholder return of 143.2%, suggesting momentum has been building over time as the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1801/innovent-biologics-shares/news/a-look-at-innovent-biologics-sehk1801-valuation-after-recent","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2097828631.EUR","DCF","LU2488822045.USD","BK1589","01801","LU2097828557.USD","LU2328871848.SGD","LU0455707207.USD","LU1969619763.USD","HK0000165453.HKD","LU2097828474.EUR","LU2097828714.EUR","LU2242644610.SGD","BK1583","LU2097828805.USD","BK1161","LU0502904849.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.innoventbio.com","stockEarnings":[{"period":"1week","weight":-0.0623},{"period":"1month","weight":0.0394},{"period":"3month","weight":0.0251},{"period":"6month","weight":0.0029},{"period":"1year","weight":0.5614},{"period":"ytd","weight":0.1252}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Innovent Biologics Inc is an investment holding company principally engaged in the research, development, production and sales of innovative medicines for the treatment of diseases such as cancer, cardiovascular and metabolic (CVM), autoimmune and eye diseases. The pipeline covering monoclonal antibodies, multi-specific antibodies, immuno-cytokine, antibody-drug conjugates (ADCs), cell therapy and small molecules. The Company’s main products include TYVYT (sintilimab injection), BYVASDA (bevacizumab injection), SULINNO (adalimumab injection), HALPRYZA (rituximab injection), Pemazyre (pemigatinib) and others. The Company mainly conducts its businesses within domestic and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.041076},{"month":2,"riseRate":0.75,"avgChangeRate":0.110526},{"month":3,"riseRate":0.25,"avgChangeRate":-0.01934},{"month":4,"riseRate":0.75,"avgChangeRate":0.037039},{"month":5,"riseRate":0.428571,"avgChangeRate":0.027398},{"month":6,"riseRate":0.714286,"avgChangeRate":0.139165},{"month":7,"riseRate":0.428571,"avgChangeRate":0.010056},{"month":8,"riseRate":0.714286,"avgChangeRate":0.000214},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032182},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.02286},{"month":11,"riseRate":0.625,"avgChangeRate":0.079172},{"month":12,"riseRate":0.375,"avgChangeRate":0.024026}],"exchange":"SEHK","name":"INNOVENT BIO","nameEN":"INNOVENT BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INNOVENT BIO(01801),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INNOVENT BIO(01801) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INNOVENT BIO,01801,INNOVENT BIO股票,INNOVENT BIO股票老虎,INNOVENT BIO股票老虎国际,INNOVENT BIO行情,INNOVENT BIO股票行情,INNOVENT BIO股价,INNOVENT BIO股市,INNOVENT BIO股票价格,INNOVENT BIO股票交易,INNOVENT BIO股票购买,INNOVENT BIO股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INNOVENT BIO(01801),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INNOVENT BIO(01801) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}